Danaher Corporation $DHR Stock Position Cut by SVB Wealth LLC

SVB Wealth LLC lessened its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 20.6% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 9,333 shares of the conglomerate’s stock after selling 2,419 shares during the quarter. SVB Wealth LLC’s holdings in Danaher were worth $2,068,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Main Street Group LTD bought a new stake in shares of Danaher during the first quarter worth $25,000. N.E.W. Advisory Services LLC bought a new position in shares of Danaher in the second quarter worth about $25,000. Marquette Asset Management LLC grew its holdings in shares of Danaher by 192.1% in the third quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock worth $25,000 after purchasing an additional 73 shares during the last quarter. Field & Main Bank purchased a new position in Danaher in the 2nd quarter worth about $29,000. Finally, Solstein Capital LLC purchased a new position in Danaher in the 2nd quarter worth about $33,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of Danaher stock opened at $233.16 on Monday. The company has a current ratio of 1.63, a quick ratio of 1.29 and a debt-to-equity ratio of 0.45. The stock’s fifty day moving average price is $222.56 and its 200-day moving average price is $201.52. The firm has a market cap of $164.04 billion, a P/E ratio of 38.16, a P/E/G ratio of 2.93 and a beta of 0.76. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80.

Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share for the quarter, topping analysts’ consensus estimates of $1.92 by $0.19. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The company had revenue of $6.55 billion during the quarter, compared to analyst estimates of $6.56 billion. During the same period in the prior year, the firm earned $1.89 earnings per share. The firm’s revenue for the quarter was up 8.3% compared to the same quarter last year. On average, equities research analysts expect that Danaher Corporation will post 8.59 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th were issued a $0.40 dividend. The ex-dividend date was Wednesday, September 30th. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. Danaher’s payout ratio is currently 26.19%.

Analyst Ratings Changes

DHR has been the subject of a number of research analyst reports. TD Cowen lifted their price objective on shares of Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a report on Thursday, October 22nd. The Goldman Sachs Group restated a “buy” rating and issued a $275.00 target price on shares of Danaher in a research note on Thursday, October 22nd. JPMorgan Chase & Co. raised their target price on shares of Danaher from $250.00 to $270.00 and gave the stock an “overweight” rating in a research report on Thursday, October 22nd. Guggenheim boosted their price target on Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a report on Thursday, October 1st. Finally, Citigroup boosted their price target on Danaher from $230.00 to $270.00 and gave the company a “buy” rating in a report on Thursday, October 22nd. Eighteen research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, Danaher has an average rating of “Moderate Buy” and a consensus price target of $242.91.

Check Out Our Latest Stock Report on DHR

Insider Activity

In other news, CAO Christopher Bouda sold 7,598 shares of the stock in a transaction that occurred on Wednesday, October 28th. The shares were sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the transaction, the chief accounting officer directly owned 9,107 shares in the company, valued at approximately $2,136,137.92. This trade represents a 45.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Gregory M. Milosevich sold 2,100 shares of Danaher stock in a transaction that occurred on Monday, November 9th. The shares were sold at an average price of $230.62, for a total transaction of $484,302.00. Following the transaction, the executive vice president directly owned 22,367 shares in the company, valued at approximately $5,158,277.54. The trade was a 8.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 10.80% of the company’s stock.

About Danaher

(Free Report)

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.

Further Reading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.